Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohamed A Sherif

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
NPJ Schizophrenia|September 22, 2020
In silico hippocampal modeling for multi-target pharmacotherapy in schizophreniaMohamed A Sherif, Samuel A Neymotin, William W Lytton
The European Journal of Neuroscience|December 17, 2017
Cannabinoid-glutamate interactions and neural oscillations: implications for psychosisMohamed A Sherif, Jose A Cortes-Briones, Mohini Ranganathan, et al.
Frontiers in Integrative Neuroscience|January 27, 2023
Understanding cingulotomy's therapeutic effect in OCD through computer modelsMohamed A Sherif, Aryandokht Fotros, Benjamin D Greenberg, et al.
Frontiers in Psychiatry|March 13, 2023
Synapses, predictions, and prediction errors: A neocortical computational study of MDD using the temporal memory algorithm of HTMMohamed A Sherif, Mostafa Z Khalil, Rammohan Shukla, et al.
Neural Computation|March 4, 2015
Neuronal calcium wave propagation varies with changes in endoplasmic reticulum parameters: a computer modelSamuel A Neymotin, Robert A McDougal, Mohamed A Sherif, et al.
Brain Informatics|May 11, 2017
Multiscale modeling in the clinic: diseases of the brain and nervous systemWilliam W Lytton, Jeff Arle, Georgiy Bobashev, et al.
The Lancet. Psychiatry|December 12, 2018
Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trialDeepak Cyril D'Souza, Jose Cortes-Briones, Gina Creatura, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 20, 2022
Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trialChadi G Abdallah, John D Roache, Ralitza Gueorguieva, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 11, 2022
Correction to: Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trialChadi G Abdallah, John D Roache, Ralitza Gueorguieva, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
NPJ Schizophrenia|September 22, 2020
In silico hippocampal modeling for multi-target pharmacotherapy in schizophreniaMohamed A Sherif, Samuel A Neymotin, William W Lytton
The European Journal of Neuroscience|December 17, 2017
Cannabinoid-glutamate interactions and neural oscillations: implications for psychosisMohamed A Sherif, Jose A Cortes-Briones, Mohini Ranganathan, et al.
Frontiers in Integrative Neuroscience|January 27, 2023
Understanding cingulotomy's therapeutic effect in OCD through computer modelsMohamed A Sherif, Aryandokht Fotros, Benjamin D Greenberg, et al.
Frontiers in Psychiatry|March 13, 2023
Synapses, predictions, and prediction errors: A neocortical computational study of MDD using the temporal memory algorithm of HTMMohamed A Sherif, Mostafa Z Khalil, Rammohan Shukla, et al.
Neural Computation|March 4, 2015
Neuronal calcium wave propagation varies with changes in endoplasmic reticulum parameters: a computer modelSamuel A Neymotin, Robert A McDougal, Mohamed A Sherif, et al.
Brain Informatics|May 11, 2017
Multiscale modeling in the clinic: diseases of the brain and nervous systemWilliam W Lytton, Jeff Arle, Georgiy Bobashev, et al.
The Lancet. Psychiatry|December 12, 2018
Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trialDeepak Cyril D'Souza, Jose Cortes-Briones, Gina Creatura, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 20, 2022
Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trialChadi G Abdallah, John D Roache, Ralitza Gueorguieva, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 11, 2022
Correction to: Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trialChadi G Abdallah, John D Roache, Ralitza Gueorguieva, et al.
Pageof 1